319 related articles for article (PubMed ID: 33306189)
1. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review.
Calanzani N; Druce PE; Snudden C; Milley KM; Boscott R; Behiyat D; Saji S; Martinez-Gutierrez J; Oberoi J; Funston G; Messenger M; Emery J; Walter FM
Adv Ther; 2021 Feb; 38(2):793-834. PubMed ID: 33306189
[TBL] [Abstract][Full Text] [Related]
2. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Lower Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.
Druce P; Calanzani N; Snudden C; Milley K; Boscott R; Behiyat D; Martinez-Gutierrez J; Saji S; Oberoi J; Funston G; Messenger M; Walter FM; Emery J
Adv Ther; 2021 Jun; 38(6):3032-3065. PubMed ID: 33907946
[TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol.
Gheytanchi E; Madjd Z; Janani L; Rasti A; Ghods R; Atyabi F; Asadi-Lari MH; Babashah S
Syst Rev; 2017 Nov; 6(1):228. PubMed ID: 29149908
[TBL] [Abstract][Full Text] [Related]
4. Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms.
Honda K; Kobayashi M; Okusaka T; Rinaudo JA; Huang Y; Marsh T; Sanada M; Sasajima Y; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Miura N; Kamita M; Sakamoto T; Shoji H; Jung G; Srivastava S; Yamada T
Sci Rep; 2015 Nov; 5():15921. PubMed ID: 26549697
[TBL] [Abstract][Full Text] [Related]
5. Anxiety and depression prevalence in digestive cancers: a systematic review and meta-analysis.
Zamani M; Alizadeh-Tabari S
BMJ Support Palliat Care; 2023 Dec; 13(e2):e235-e243. PubMed ID: 34417285
[TBL] [Abstract][Full Text] [Related]
6. Circulating Biomarkers for the Early Diagnosis of Gastrointestinal Cancers.
Nellore J; Narayan AS; Sunkar S; Nachiyar CV; Jayakrishna T; Peela S
Crit Rev Oncog; 2020; 25(4):335-354. PubMed ID: 33639061
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Dumstrei K; Chen H; Brenner H
Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review.
Xue J; Jia E; Ren N; Lindsay A; Yu H
Onco Targets Ther; 2019; 12():6665-6684. PubMed ID: 31692495
[TBL] [Abstract][Full Text] [Related]
9. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.
Anderson BW; Ahlquist DA
Gastroenterol Clin North Am; 2016 Sep; 45(3):529-42. PubMed ID: 27546847
[TBL] [Abstract][Full Text] [Related]
10. The Upper Gastrointestinal Cancer Registry (UGICR): a clinical quality registry to monitor and improve care in upper gastrointestinal cancers.
Maharaj AD; Holland JF; Scarborough RO; Evans SM; Ioannou LJ; Brown W; Croagh DG; Pilgrim CHC; Kench JG; Lipton LR; Leong T; McNeil JJ; Nikfarjam M; Aly A; Burton PR; Cashin PA; Chu J; Duong CP; Evans P; Goldstein D; Haydon A; Hii MW; Knowles BPF; Merrett ND; Michael M; Neale RE; Philip J; Porter IWT; Smith M; Spillane J; Tagkalidis PP; Zalcberg JR
BMJ Open; 2019 Sep; 9(9):e031434. PubMed ID: 31575580
[TBL] [Abstract][Full Text] [Related]
11. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
12. Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bos ACRK; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1237-1243.e2. PubMed ID: 29427732
[TBL] [Abstract][Full Text] [Related]
13. Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Bussom S; Saif MW
JOP; 2010 Mar; 11(2):128-30. PubMed ID: 20208319
[TBL] [Abstract][Full Text] [Related]
14. Alarm symptoms of upper gastrointestinal cancer and contact to general practice--A population-based study.
Rasmussen S; Larsen PV; Svendsen RP; Haastrup PF; Søndergaard J; Jarbøl DE
Scand J Gastroenterol; 2015; 50(10):1268-75. PubMed ID: 25877333
[TBL] [Abstract][Full Text] [Related]
15. Real-time artificial intelligence for detection of upper gastrointestinal cancer by endoscopy: a multicentre, case-control, diagnostic study.
Luo H; Xu G; Li C; He L; Luo L; Wang Z; Jing B; Deng Y; Jin Y; Li Y; Li B; Tan W; He C; Seeruttun SR; Wu Q; Huang J; Huang DW; Chen B; Lin SB; Chen QM; Yuan CM; Chen HX; Pu HY; Zhou F; He Y; Xu RH
Lancet Oncol; 2019 Dec; 20(12):1645-1654. PubMed ID: 31591062
[TBL] [Abstract][Full Text] [Related]
16. An Asian consensus on standards of diagnostic upper endoscopy for neoplasia.
Chiu PWY; Uedo N; Singh R; Gotoda T; Ng EKW; Yao K; Ang TL; Ho SH; Kikuchi D; Yao F; Pittayanon R; Goda K; Lau JYW; Tajiri H; Inoue H
Gut; 2019 Feb; 68(2):186-197. PubMed ID: 30420400
[TBL] [Abstract][Full Text] [Related]
17. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
[TBL] [Abstract][Full Text] [Related]
18. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
Kumar Y; Tapuria N; Kirmani N; Davidson BR
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
[TBL] [Abstract][Full Text] [Related]
19. Oral Microbiota as Promising Diagnostic Biomarkers for Gastrointestinal Cancer: A Systematic Review.
Chen Y; Chen X; Yu H; Zhou H; Xu S
Onco Targets Ther; 2019; 12():11131-11144. PubMed ID: 31908481
[TBL] [Abstract][Full Text] [Related]
20. Comparing the diagnostic accuracy of five common tumour biomarkers and CA19-9 for pancreatic cancer: a protocol for a network meta-analysis of diagnostic test accuracy.
Ge L; Pan B; Song F; Ma J; Zeraatkar D; Zhou J; Tian J
BMJ Open; 2017 Dec; 7(12):e018175. PubMed ID: 29282264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
